盐酸头孢替安，CAS 登记号 66309-69-1，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于医药中间体及原料药。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
医药中间体及原料药
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 盐酸头孢替安 的 CAS 号：66309-69-1，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及医药中间体及原料药。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
cefotiam hydrochloride · CAS 66309-69-1 · C18H25Cl2N9O4S3. UNII H7V12WDZ93.
| CAS Registry Number | 66309-69-1 |
|---|---|
| PubChem CID | 47896 |
| Molecular formula | C18H25Cl2N9O4S3 |
| IUPAC name | (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)acetyl]amino]-3-[[1-[2-(dimethylamino)ethyl]tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;dihydrochloride |
| UNII (FDA) | H7V12WDZ93 |
| Molecular Weight | 598.6 |
|---|---|
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 10 |
| Exact Mass | 597.0568692 |
| Monoisotopic Mass | 597.0568692 |
| Topological Polar Surface Area | 251 |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 847 |
| Reported hazard statements | H315 (50%), H317 (83.3%), H319 (66.7%), H334 (83.3%) |
|---|
H315 (50%): Causes skin irritation [Warning Skin corrosion/irritation]
H317 (83.3%): May cause an allergic skin reaction [Warning Sensitization, Skin]
Cefotiam dihydrochloride; CEFOTIAM HYDROCHLORIDE; 66309-69-1; Cefotiam hcl; Ceradon; Abbott-48999; SCE 963; Abbott 48999; CGP-14221/E; SCE-963; H7V12WDZ93; NSC-758164; CHEBI:31374; DTXSID1045538; Abbott48999; Hydrochloride, Cefotiam
CAS 66309-69-1; molecular formula C18H25Cl2N9O4S3; molecular weight — g/mol.
Cefotiam dihydrochloride, CEFOTIAM HYDROCHLORIDE, 66309-69-1, Cefotiam hcl, Ceradon, Abbott-48999.
Hazard statements reported: H315, H317, H319, H334.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.